This raises the fascinating possibility that cAMP signalling is a negative regulator of invasiveness in breast cancer, and further work will be necessary to elucidate how this is linked to trafficking of MT1-MMP and possibly to other pro-invasive receptors that cycle through the endosomal system. This evidence concerns the gene MMP14 and breast carcinoma.